DexCom (DXCM) Misses Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
DexCom, Inc. Reports First Quarter 2015 Financial Results
April 29, 2015 4:01 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2015.
Total revenue grew to $72.8 million for the first quarter of 2015, an increase of 55% from the same quarter in 2014. Total gross profit totaled $46.5 million for the three months ended March 31, 2015, compared to a total gross profit of $29.8 million for the three months ended March 31, 2014. In conjunction with the FDA approval and launch of the G4 PLATINUM with Share during the first quarter of 2015, the Company deferred revenue of $0.8 million primarily attributed to an... More



